Researchers harness AI power to predict right ventricle issues from electrocardiograms, promising more innovative tools and improved patient outcomes. The study departs from traditional methods, predicting something not easily quantifiable by other common tests.
Researchers unveiled mEnrich-seq, a method to enhance microbiome research specificity and efficiency. The technique helps identify specific bacteria in complex environments, facilitating study of diverse biomedical questions.
Researchers at Icahn School of Medicine at Mount Sinai developed a novel genetic priority score (GPS) to integrate various types of human genetic data for easy target prioritization. The tool identifies genes with high potential for clinical trial success, particularly those with demonstrated genetic support.
A Mount Sinai study found that human beliefs about nicotine can modulate brain activities in a way comparable to pharmacology, with potential implications for addiction treatment. The study used fMRI to explore the relationship between subjective beliefs and biological substrates in the human brain.
Researchers uncovered insights into TAAR1's mechanism of action, highlighting significant differences between human and rodent models. The study suggests species-specific differences in drug-receptor interactions, paving the way for improved medications targeting substance use disorders.
Researchers found strong associations between neighborhood prevalence of chronic conditions like CKD, diabetes, and hypertension and structural racism indicators. The study used data from Durham County, North Carolina, to explore the interplay between racism and poor health outcomes.
Researchers have gained a deeper understanding of the nuanced roles of JAK inhibitors in inflammation across various cell types and tissues. The study reveals that activating JAK1 signaling has tissue-specific effects, including an unexpected immunoregulatory role in lung sensory neurons, which suppresses lung inflammation.
A team of scientists has developed a statistical technique called BridgePRS to enhance disease prediction in people of non-European ancestry, particularly those of African descent. This advancement aims to reduce health care inequities and enable more personalized medical interventions based on genetic information.
The Mount Sinai Hospital has received a $1.3 million grant from the National Institutes of Health to expand its New York City Virus Hunters program. The program engages high school students in virus surveillance and mapping, tracking circulating avian influenza and paramyxoviruses in wild birds.
Researchers developed an innovative machine learning tool, LoGoFunc, to predict pathogenic gain- and loss-of-function variants across the human genome. The tool distinguishes between different types of harmful mutations, offering valuable insights into diverse disease outcomes.
Researchers identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer. Combining immunotherapy with dupilumab boosted patients' immune systems and showed significant tumor reduction in six out of six cases.
A new study found that traumatic memories in people with PTSD are represented in the brain in a distinct way, deviating from regular memory processing. The hippocampus and posterior cingulate cortex regions showed different neural responses to traumatic and sad autobiographical memories.
Mount Sinai researchers have found that testosterone treatment is safer than previously reported, with a smaller degree of change in hematocrit levels. The study, involving over 6,670 transmasculine patients, suggests that providers can feel more comfortable prescribing testosterone as part of gender-affirming hormone therapy.
A randomized controlled trial found that significant price discounts on healthful foods like vegetables and zero-calorie beverages lead to increased consumption of these items. The study suggests that subsidies or modifications to the Farm Bill could promote healthier dietary intake behaviors.
The Icahn School of Medicine at Mount Sinai has been awarded a $5 million NIH grant to establish a state-of-the-art center dedicated to discovering and developing novel therapeutic targets for cancer therapy. The Center will utilize cutting-edge technologies and interdisciplinary collaborations to accelerate the translation of scientif...
Researchers at Mount Sinai Center for Transformative Disease Modeling identified 4,749 key gene clusters that significantly influence the progression of 32 different types of cancer. The study provides a comprehensive resource for developing next-generation cancer treatments and diagnostic markers.
A new study published in Radiology shows that patients diagnosed with lung cancer via CT screening have a 20-year survival rate of 81 percent, significantly higher than the average five-year survival rate for all lung cancer patients. Early detection through routine screening can lead to a cure if found early.
Researchers shed light on TIMP2's role in regulating hippocampal plasticity and function, which decreases with age. Targeting the extracellular matrix may improve plasticity in the brain, offering new directions for mitigating neurodegenerative disorders.
A new study reveals that women with atrial fibrillation (AF) have comparable outcomes to men when undergoing pulsed field ablation (PFA), a safer and more precise procedure. The results show improved AF recurrence rates in women after PFA, making them an eligible candidate for this life-enhancing treatment.
A large brain autopsy study of women who experienced intimate partner violence found substantial vascular and white matter damage, but no evidence of chronic traumatic encephalopathy. The study also revealed significant medical comorbidity, including cardiovascular and cerebrovascular disease.
A recent study published in eBioMedicine found an association between certain per- and polyfluoroalkyl substances (PFAS) and an increased risk of thyroid cancer. The researchers investigated plasma PFAS levels in thyroid cancer patients and non-cancer controls, finding a significant positive association with exposure to n-PFOS.
A clinical trial has shown that combining chemotherapy with immunotherapy nivolumab significantly improved outcomes in patients with advanced bladder cancer. The study found nearly twice as many patients with no evidence of disease after treatment, and a median complete response of 37.1 months.
Researchers created the first 'multiome' atlas of brain cell development in the human cerebral cortex, revealing specific changes in chromatin structure that precede gene expression. The study pinpointed regions associated with genes linked to neuropsychiatric disorders like schizophrenia and bipolar disorder.
Researchers from Icahn School of Medicine at Mount Sinai and the University of California San Diego will lead a new data integration hub aiming to accelerate novel therapeutics and cures for diseases. The grant, worth $8.5 million, is part of the NIH Common Fund's efforts to enhance data findability, accessibility, interoperability, an...
Researchers at Mount Sinai Hospital developed an algorithm called HistoAge that predicts age at death based on human brain tissue specimens using artificial intelligence, revealing insights into aging mechanisms and neurodegenerative diseases like Alzheimer's disease.
Researchers found that using predictive models in healthcare can alter relationships between patient data and outcomes, leading to further degradation. Implementing a system to track individuals impacted by machine learning predictions is crucial to maintaining model performance.
Researchers have developed a new approach to treating invasive bladder cancer, combining chemotherapy and immunotherapy, which may preserve quality of life. In a phase 2 clinical trial, approximately 43% of patients achieved complete response without surgical removal of the bladder.
Researchers will investigate risk factors for malignant arrhythmias in mitral valve prolapse, aiming to develop novel indicators and improve patient outcomes. The study will use imaging technology and combine it with other markers to predict the development of arrhythmias over a five-year period.
Researchers identified specific blood biomarkers that can accurately identify patients with long COVID, revealing distinct immune and hormone function differences. The study also found abnormal T cell activity, reactivation of latent viruses, and reduced cortisol levels in patients with long COVID.
Researchers discovered a convergence in potent suppression of interferon-stimulated genes through several viral proteins, including Orf6 and Orf9b, which serve as innate immune antagonist proteins. These findings provide potential new ways to address viral pandemics by targeting a common pathway that the virus uses for infectivity.
A team of researchers has identified a unique pattern in brain activity that reflects the recovery process in patients with treatment-resistant depression. After six months of deep-brain stimulation therapy, 90% of patients exhibited significant improvement in their symptoms and 70% no longer met the criteria for depression.
The Mount Sinai Hospital's Cohen Center will expand its research and clinical care to include 'long Lyme Disease/Lyme+', exploring key similarities and differences with long COVID. The center will offer novel therapies, including virtual reality and non-invasive brain stimulation technologies, as well as personalized cognitive rehabili...
A systematic review of 117 reports from 19 countries found that over half of volunteer community health care workers experience labor exploitation, including sub-minimum-wage pay and excess work hours. The study highlights the need for fair compensation and safe working conditions to improve quality of care and overall health outcomes.
Researchers found that preschoolers from low-income families had poorer health outcomes and improved less in healthy lifestyle habits compared to their peers from more affluent backgrounds. The intervention program showed significant improvements in knowledge, attitudes, and behaviors among children with higher socioeconomic status, bu...
The Mount Sinai Hospital received a $13 million NIH grant to create vaccines that can protect against various types of coronaviruses. The project aims to develop variant-proof, universal vaccines that offer broad protection against existing and future SARS-CoV-2 variants, pandemic, zoonotic, and seasonal coronaviruses.
Researchers have developed an automated breath-by-breath measure to assess the severity of obstructive sleep apnea, predicting cardiovascular disease and mortality. The ventilatory burden tool provides a validated alternative to AHI, offering stable results and risk predictions.
Researchers at Mount Sinai identified the structure of a red blood cell transporter and how it interacts with drugs. They discovered novel compounds capable of blocking the transporter, potentially leading to new treatments for conditions like hemolytic anemias.
Researchers from Mount Sinai found that Asian Americans have a significantly high exposure to PFAS, with median exposure scores 89% higher than non-Hispanic whites. The study used advanced data science methods to account for complex exposure sources and heterogeneity across different groups.
A Mount Sinai study identified the most effective and safest outpatient labor induction methods, using low-dose vaginal misoprostol, which reduces hospital stays and increases hospital efficiency. The study found that this approach does not increase cesarean delivery risk or complications.
Researchers found that the flu blocks lung liquid secretion, allowing staph to infect lungs. Treatment with a CFTR-activating drug like ivacaftor restores liquid secretion and protects against staph infection.
Researchers have discovered a 64-protein signature that can predict which ovarian cancer patients are unlikely to respond to chemotherapy, paving the way for personalized treatment options. The study also identifies five new subtypes of high-grade serous ovarian cancer, suggesting different treatment strategies may be needed.
Researchers aim to understand how psychosocial stress influences cardiovascular health and develop interventions to modulate its effects. The team plans to broaden their perspective on immune reprogramming in stress-aggravated atherosclerotic disease.
Researchers have developed an innovative RNA-based strategy to activate dendritic cells, which play a key role in immune response. The approach, called CATCH, eradicated tumors and prevented their recurrence in mouse models of melanoma, suggesting its potential effectiveness against different cancer types.
A Mount Sinai study published in Nicotine & Tobacco Research found that cigarette smokers are more likely to experience tobacco dependence compared to those who use smokeless tobacco or multiple products. The researchers identified three distinct groups of tobacco users and suggested tailored cessation programs for each group.
Researchers at Mount Sinai discovered a new family of locally secreted molecules called 'mammokines' that play a crucial role in controlling mammary gland fat abundance. These findings have significant implications for breast health, lactation-related disorders, and metabolic syndromes.
A recent study has found that babies born to fathers with psychiatric diagnoses are more likely to be born prematurely. The study analyzed data from over 1.5 million births in Sweden and found a significant increase in preterm births among infants whose father had a psychiatric diagnosis.
Researchers found that individuals with heroin use disorder exhibited a bias towards processing drug cues, while healthy controls showed the opposite pattern. This suggests that efforts to downregulate responses to drug cues may come at the cost of amplifying responses to natural rewards.
A new AI model predicts which existing medicines may lead to congenital disabilities by analyzing genetic associations, drug targets, and gene expression changes. The study's findings have the potential to improve reproductive health and fetal development by identifying potential toxins in new drugs.
Researchers identified significant differences between individuals with CHAMP1 coding mutations and deletions, affecting adaptive functioning skills and severity of symptoms. The study highlights the importance of understanding genetic mechanisms to develop precision medicine approaches for treating CHAMP1 disorder.
Researchers aim to prevent transplant rejection by targeting trained immunity, a newly explored part of the immune system. The five-year program will investigate how trained immunity drives rejection and develop tools for diagnosing and regulating it.